Physician

Jing Li, M.D.

According to 2025 Medicare claims, Jing Li, M.D. (NPI: 1659551604) practices hematology/oncology in the Charlotte-Concord-Gastonia, NC-SC market, with the plurality of this provider's patient population coming from Iredell, NC. This provider's primary affiliated billing organization is WAKE FOREST UNIVERSITY HEALTH SCIENCES (NPI: 1003803032; TIN: 223849199) and primary practice location at 28677-4103. Li is affiliated with the Advocate Physician Partners Accountable Care, Inc. (ACO ID: A1033), participating under the MSSP model.

Li's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 469 traditional Medicare patients, billed 121,435 HCPCS/CPT codes, and received $1,872,780 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 2,583 prescription claims across 370 beneficiaries totaling $5,569,168 in drug costs, led by Imbruvica (Ibrutinib). 2021 DME data shows 55 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $135,718 to $1,872,780. Similarly, Part D prescription costs have moved sharply higher in recent years, from $3,413 to $5,569,168. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	89	14,176	$135,718
2016	209	47,192	$413,924
2017	267	64,323	$502,347
2018	245	106,404	$1,122,442
2019	299	79,890	$1,265,065
2020	300	84,960	$1,372,001
2021	333	90,625	$1,391,659
2022	369	77,190	$1,171,548
2023	358	52,353	$1,150,085
2024	469	121,435	$1,872,780

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	28	128	$3,413
2016	70	436	$154,403
2017	100	682	$182,142
2018	130	905	$408,609
2019	131	967	$873,151
2020	166	1,307	$1,987,281
2021	201	1,382	$2,385,627
2022	275	1,724	$3,700,790
2023	286	2,009	$4,020,529
2024	370	2,583	$5,569,168

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	11	$207
2018	N/R	33	$8,043
2019	N/R	N/R	N/R
2020	N/R	15	$2
2021	N/R	55	$10
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	64	73	$112
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	319	802	$87
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	161	229	$60
80053	Blood test, comprehensive group of blood chemicals	56	325	$10
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	378	1,079	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Imbruvica	Ibrutinib	41	1,129	$933,552
Xtandi	Enzalutamide	66	1,980	$914,231
Revlimid	Lenalidomide	44	1,232	$764,051
Ibrance	Palbociclib	21	588	$335,877
Jakafi	Ruxolitinib Phosphate	19	570	$299,838

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Jing Li, M.D.?

Tedicare shows public-source Medicare data for Jing Li, M.D. (NPI 1659551604), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jing Li, M.D. have ACO affiliation data?

Jing Li, M.D. is shown with ACO affiliation data for Advocate Physician Partners Accountable Care, Inc. (MSSP, ACO ID A1033).

What billing organization is linked to Jing Li, M.D.?

Jing Li, M.D. is linked to WAKE FOREST UNIVERSITY HEALTH SCIENCES (billing NPI 1003803032) in the available physician profile data.

Does Jing Li, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.